USPTO serial 87194610
CULLINAN
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- CLYBURN, CARLA DIONNE
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with CULLINAN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Gwenn Roos
GWENN ROOS LAW OFFICE OF GWENN ROOS26 BROOKDALE AVENUEWELLESLEY, MA 02482UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 036 | Advice relating to investments; Brokerage services for capital investments; Business brokerage services and related consulting pertaining to business sales, mergers, acquisitions and business valuations; Business equity research; Business finance procurement services; Capital investment; Capital investment consulting; Capital investment services; Consultancy of capital investment; Debt management consultation; Equity capital investment; Facilitating and arranging for the financing of start up ventures in the field of oncology, pharmaceuticals, and therapeutics; Fiduciary representatives; Financial advice; Financial advice and consultancy services; Financial advisory and consultancy services; Financial and investment services, namely, asset and investment acquisition, consultation, advisory and development; Financial consultancy; Financial consultancy services in the area of healthcare; Financial consultation; Financial consultation in the field of oncology and therapeutic products for the pharma industry; Financial consulting; Financial due diligence; Financial investment in the field of oncology and therapeutic products for the pharma industry; Financial loan consultation; Financial portfolio management; Financial research and information services; Financial restructuring services; Financial services in the nature of an investment security; Financial services, namely, raising debt and equity capital for others; Fundraising for others for the purpose of purchasing companies; Funds investment; Incubation services, namely, providing financing to freelancers, start-ups, existing businesses and non-profits; Incubation services, namely, rental of office space to freelancers, start-ups, existing businesses and non-profits; Information, advisory, consultancy and research services relating to finance and investments; Investment advisory services; Investment consultancy; Investment consultation; Investment management; Investment management in the fields of oncology and therapeutic products for the pharma industry; Investment management services in the field of acquiring joint ventures; Investment services, namely, asset acquisition, consultation, development and management services; Management of a capital investment fund; Management of private equity funds; Mutual funds and capital investment; Private equity consultant services; Private equity fund investment services; Providing financial information; Providing fundraising services for others via a global computer network; Providing investors with financial information; Providing loans secured by commercial paper; Providing venture capital, development capital, private equity and investment funding; Providing working capital; Providing working capital financing to small businesses and small business owners; Provision of financial information; Public equity investment management; Strategic corporate financial advisory services; Strategic financial advisory services; Venture capital advisory services; Venture capital financing; Venture capital fund management; Venture capital funding services to emerging and start-up companies; Venture capital services, namely, providing financing to emerging and start-up companies | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CULLINAN ONCOLOGY, LLC
- Other trademarks owned by Cullinan Pharmaceuticals, LLC
- Other trademarks owned by Cullinan Pharmaceuticals, LLC
- Other trademarks in Class 036
- Similar marks named CULLINAN
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 8, 2019 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 8, 2019 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 20, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 19, 2018 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Dec 17, 2018 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Dec 16, 2018 | TPEX | SOU EXTENSION RECEIVED WITH TEAS PETITION | — |
| Dec 16, 2018 | PETG | PETITION TO REVIVE-GRANTED | — |
| Dec 16, 2018 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Dec 5, 2018 | EXT2 | SOU EXTENSION 2 FILED | — |
| Sep 11, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 10, 2018 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Sep 10, 2018 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Aug 1, 2018 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jul 23, 2018 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Jul 22, 2018 | TPEX | SOU EXTENSION RECEIVED WITH TEAS PETITION | — |
| Jul 22, 2018 | PETG | PETITION TO REVIVE-GRANTED | — |
| Jul 22, 2018 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Jul 9, 2018 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 9, 2018 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 5, 2018 | EXT1 | SOU EXTENSION 1 FILED | — |
| Dec 5, 2017 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 10, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 10, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 20, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 31, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 31, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 31, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 31, 2017 | ALIE | ASSIGNED TO LIE | — |
| Aug 16, 2017 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Aug 15, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 15, 2017 | PETG | PETITION TO REVIVE-GRANTED | — |
| Aug 15, 2017 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Jan 18, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 18, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 18, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 18, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 18, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 18, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 17, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 11, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 10, 2016 | NWAP | NEW APPLICATION ENTERED | — |